Immunohistochemical analysis of BRCA1 expression in normal human buccal cells

Oncology Reports

Volumn 5, Issue 5, 1998, Pages 1071-1076

  Reece, M T ^a   Lane, M A ^a   Byrne, T J ^b   Adams, L A ^a   Podgaysky, A P ^a   Cohn, G M ^a  

^a BAYSTATE MEDICAL CENTER   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

BRCA1; Buccal cells

Indexed keywords

BRCA1 PROTEIN; MESSENGER RNA;

ARTICLE; CHEEK MUCOSA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MALE; ONCOGENE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031857621     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.5.1071     Document Type: Article

References (42)

1. Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, Hoskins K, Weber B, Castilla L, Erdos M, Brody L, Friedman L, Ostermyer E, Szabo C, King M-C, Jhanwar S, Offit K, Norton L, Gilewski T, Lubin M, Osborne M, Black D, Boyd M, Steel M, Ingles S, Haile R, Linblom A, Olsson H, Borg A, Bishop DT, Solomon E, Radice P, Spatti G, Gayther S, Ponder B, Warrren W, Stratton M, Liu Q, Fujimura F, Lewis C, Skolnick MH and Goldar DEA: A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. JAMA 273: 535-541, 1995.
2. Szabo CI and King MC: Inherited breast and ovarian cancer. Hum Mol Genet 4: 1811-1817, 1995.
3. Xu CR and Solomon E: Mutations of the BRCA1 gene in human cancer. Semin Cancer Biol 7: 33-40, 1996.
4. Holt JT, Thompson ME, Szabo C, Robinson-Benion C, Arteaga CL, King M-C and Jensen RA: Growth retardation and tumour inhibition by BRCA1. Nat Genet 12: 298-302, 1996.
5. Shao N, Chai YL, Shyam E, Reddy P and Rao VN: Induction of apoptosis by the tumor suppresssor protein BRCA1. Oncogene 13: 1-7, 1996.
6. Rao VN, Shao N, Ahmad M and Reddy ESP: Antisense RNA to the putative tumor suppresser gene BRCA1 transforms mouse fibroblasts. Oncogene 12: 523-528, 1996.
7. Thompson ME, Jensen RA, Obermiller PS, Page DL and Holt JT: Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet 9: 444-450, 1995.
8. Sobol H, Stoppa-Lyonnet D, Bressac-de-Paillerets B, Peyrat J-P, Kerangueven F, Janin N, Noguchi T, Eisinger F, Guinebretiere J-M, Jacquemier J and Birnbaum D: Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancers. Cancer Res 56: 3216-3219, 1996.
9. Liu C-Y, Flisken-Nikitin A, Li S, Zeng Y and Lee W-H: Inactivation of the mouse Brcal gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev 10: 1835-1843, 1996.
10. Gowan LC, Johnson BL, Latour AM, Sulik KK and Koller BH: Brcal deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat Genet 12: 191-194, 1996.
11. Ludwig T, Chapman DL, Papaioannou VE and Efstratiadis A: Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brcal, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev 11: 1226-1241, 1997.
12. Hakem R, de la Pompa JL, Sirard C, Mo R, Woo M, Hakem A, Wakeham A, Potter J, Reitmair A, Billia F, Firpo E, Hui CC, Roberts J, Rossant J and Mak TW: The tumor suppressor gene Brcal is required for embryonic cellular proliferation in the mouse. Cell 85: 1009-1023, 1996.
13. Rajan JV, Wang M, Marquis ST and Chodosh LA: Brca2 coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells. Proc Natl Acad Sci USA 93: 13078-13083, 1996.
14. Lane TF, Deng C, Elson A, Lyu MS, Kozak CA and Leder P: Expression of Brcal is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev 9: 2712-2722, 1995.
15. Zabludoff SD, Wright WW, Harshman K and Wold BJ: BRCA1 mRNA is expressed highly during meiosis and spermiogenesis but not during mitosis of male germ cells. Oncogene 13: 649-653, 1996.
16. Tirkkonen M, Johannsson O, Agnarsson BA, Olsson H, Ingvarsson S, Karhu R, Tanner M, Isola J, Barkardottir RB, Borg A and Kallioniemi O-P: Distinct somatic genetic changes associated with tomor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res 57: 1222-1227, 1997.
17. Gudas JM, Nguyen H, Li T and Cowan KH: Hormone-dependent regulation of BRCA1 in human breast cancer cells. Cancer Res 55: 4561-4565, 1995.
18. Gudas JM, Li T, Nguyen H, Jensen D, Rauscher FJ III and Cowen KH: Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. Cell Growth Differ 7: 717-723, 1996.
19. Chen Y, Farmer AA, Chen C-F, Jones DC, Chen P-L and Lee W-H: BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res 56: 3168-3172, 1996.
20. Phillips KW, Goldworth SM, Bennett LM, Brownlee HA, Wiseman RW and Davis BJ: Brcal is expressed independently of hormonal stimulation in the mouse ovary. Lab Invest 76: 419-425, 1997.
21. Marks JR, Huper G, Vaughn JP, Davis PL, Morris J, McDonnell DP, Wiseman RW, Futreal PA and Inglehart JD: BRCA1 expression is not directly responsive to estrogen. Oncogene 14: 115-121, 1997.
22. Wang SC, Lin SH, Su LK and Hung MC: Changes in BRCA2 expression during progression of the cell cycle. Biochem Biophys Res Commun 234: 247-251, 1997.
23. Jin Y, Xu XL, Yank MC, Wei F, Ayi TC, Bowcock AM and Baer R: Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains. Proc Natl Acad Sci USA 94: 12075-12080, 1997.
24. Somasundaram K, Zhang H, Zeng, YX, Houvras, Peng, Zhang H, Wu GS, Licht JD, Weber BL and El-Deiry WS: Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF/CiP1. Nature 389: 187-190, 1997.
25. Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T and Livingston DM: Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88: 265-275, 1997.
26. Callebaut I and Mornon JP: From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair. FEBS Lett 400: 25-30, 1997.
27. Vaughn JP, Davis PL, Jarboe MD, Huper G, Evans AC, Wiseman RW, Berchuck A, Inglehart JD, Futreal PA and Marks JR: BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth Differ 7: 711-715, 1996.
28. Aprelikova O, Kuthiala A, Bessho M, Ethier S and Liu ET: BRCA1 protein level is not affected by peptide growth factors in MCF10A cell line. Oncogene 13: 2487-2491, 1996.
29. Thompson MA, Adelson MD, Kaufman LM, Marshall LD and Coble DA: Aromatization of testosterone by epithelial tumor cells cultured from patients with ovarian carcinoma. Cancer Res 48: 6491-6497, 1998.
30. Scully R, Ganesan S, Brown M, deCaprio JA, Cannistra SA, Feunteun J, Schnitt S and Livingston DM: Location of BRCA1 in human breast cells and ovarian cancer cells. Science 272: 123-126, 1996.
31. Jensen RA, Thompson ME, Jetton TL, Szabo CI, van der Meer R, Helou B, Tronick SR, Page DL, King M-C and Holt JT: BRCA1 is secreted and exhibits properties of a granin. Nat Genet 12: 303-308, 1996.
32. Chen Y, Chen C-F, Riley DJ, Allred C, Chen P-L, von Hoff D, Osborne CK and Lee W-H: Aberrant subcellular localization of BRCA1 in breast cancer. Science 270: 789-791, 1995.
33. Coene E, van Oostveldt P, Willems K, van Emmelo J and dePotter CR: BRCA1 is localized in cytoplasmic tube-like invaginations in the nucleus. Nat Genet 16: 122-124, 1997.
34. Wilson CA, Payton MN, Elliott GS, Buaas FW, Cajulis EE, Grosshans D, Ramos L, Reese DM, Slamon DJ and Calzone FJ: Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-deltal 1b. Oncogene 14: 1-16, 1997.
35. Thakur S, Ahang HB, Peng Y, Le H, Carroll B, Ward T, Yao J, Farid LM, Couch FJ, Wilson RB and Weber BL: Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol Cell Biol 17: 444-452, 1997.
36. Chen C-F, Li S, Chen Y, Chen P-L, Sharp D and Lee W-H: The nuclear localization sequences of the BRCA1 protein interact with the importin-α subunit of the nuclear transport signal receptor. J Biol Chem 51: 32863-32868, 1996.
37. Lu M, Conzen SD, Cote CN and Arrick BA: Characterization of functional messenger RNA splice variants of BRCAI expressed in nonmalignant and tumor-derived breast cells. Cancer Res 56: 4578-4581, 1996.
38. Thomas JE, Smith M, Rubinfeld B, Gutowski M, Beckmann RP and Polakis P: Subcellular localization and analysis of apparent 180-kDa and 220-kDa proteins of the breast cancer susceptibility gene, BRCA1. J Biol Chem 271: 28630-28635, 1996.
39. Abel KJ, Xy J, Yin GY, Lyons RH, Meisler MH and Weber BL: Mouse Brcal: localization sequence analysis and identification of evolutionary conserved domains. Hum Mol Genet 4: 2265-2273, 1995.
40. Wang H, Shao N, Ding QM, Cui J-Q, Reddy ESP and Rao VN: BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases. Oncogene 15: 143-157, 1997.
41. Monteiro ANA, August A and Hanafusa H: Evidence for a transcriptional activation function of BRCA1 C-termmal region. Proc Natl Acad Sci USA 93: 13595-13599, 1996.
42. Bork P, Hofmann K, Bucher P, Neuwald AF, Altschul SF and Koonin EV: A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB J 11: 68-76, 1997.